Remdesivir, manufactured by US company Gilead Sciences, is currently the subject of at least four trials on coronavirus patients, including two in China. An outbreak of the Ebola virus in three African countries between 2014 and 2016 killed thousands of people. Gilead Sciences’ claim about remdesivir’s potential efficacy against coronavirus has been endorsed by the World Health Organization (WHO).
At a press briefing in Beijing, WHO assistant director-general Bruce Aylward said:
“There is only one drug right now that we think may have real efficacy, and that’s remdesivir.”